Possible involvement of differing classes of dopamine D-2 receptors in yawning and stereotypy in rats
- PMID: 1968276
- DOI: 10.1007/BF02244396
Possible involvement of differing classes of dopamine D-2 receptors in yawning and stereotypy in rats
Abstract
The present experiments were performed to investigate differences in the properties of the dopamine D-2 receptors related to yawning and stereotypy. Subcutaneous injection of talipexole (B-HT 920) (10-250 micrograms/kg) or SND 919 ((S)-2-amino-4,5,6,7-tetrahydro-6-propylamino-benzothiazole) (25-500 micrograms/kg) evoked yawning behavior with bell-shaped responses. However, SK&F 38393 (1-phenyl-2,3,4,5-tetrahydro-(1H)-3-benzazepine-7,8-diol) (0.5-10 mg/kg SC) did not elicit yawning and decreased yawning responses to low doses of talipexole (25 micrograms/kg SC) or SND 919 (100 micrograms/kg SC). These low but effective doses for inducing yawning of talipexole or SND 919 in combination with SK&F 38393 (0.5-10 mg/kg SC) did not elicit stereotypy. In contrast, yawning behavior was not produced after very high doses of talipexole (500 micrograms/kg SC) or SND 919 (1000 micrograms/kg SC) given alone or in combination with SK&F 38393 (0.5-10 mg/kg SC). These extremely high doses of talipexole or SND 919 evoked slight stereotypy, which was enhanced by the combined treatment with SK&F 38393. The present results suggest that the dopamine D-2 receptors related to yawning are more sensitive to dopamine receptor agonists than those related to stereotypy, and that concurrent stimulation of postsynaptic dopamine D-1 receptors with D-2 receptors reduces the incidence of yawning but enhances that of stereotypy.
Similar articles
-
Occurrence of yawning and decrease of prolactin levels via stimulation of dopamine D2-receptors after administration of SND 919 in rats.Naunyn Schmiedebergs Arch Pharmacol. 1989 Jul;340(1):21-5. doi: 10.1007/BF00169201. Naunyn Schmiedebergs Arch Pharmacol. 1989. PMID: 2571944
-
Potentiation of yawning responses to the dopamine receptor agonists B-HT 920 and SND 919 by pindolol in the rat.J Neural Transm Gen Sect. 1990;79(1-2):19-24. doi: 10.1007/BF01250996. J Neural Transm Gen Sect. 1990. PMID: 1967531
-
Effects of putative dopamine D3 receptor agonists, 7-OH-DPAT, and quinpirole, on yawning, stereotypy, and body temperature in rats.Pharmacol Biochem Behav. 1995 Nov;52(3):503-8. doi: 10.1016/0091-3057(95)00103-4. Pharmacol Biochem Behav. 1995. PMID: 8545466
-
Do autoreceptors mediate dopamine agonist--induced yawning and suppression of exploration? A critical review.Psychopharmacology (Berl). 1992;106(1):1-13. doi: 10.1007/BF02253581. Psychopharmacology (Berl). 1992. PMID: 1738786 Review.
-
Allosteric modulation of dopamine receptors.Mini Rev Med Chem. 2005 Jun;5(6):555-61. doi: 10.2174/1389557054023260. Mini Rev Med Chem. 2005. PMID: 15974933 Review.
Cited by
-
Perinatal Treatments with the Dopamine D₂-Receptor Agonist Quinpirole Produces Permanent D₂-Receptor Supersensitization: a Model of Schizophrenia.Neurochem Res. 2016 Feb;41(1-2):183-92. doi: 10.1007/s11064-015-1757-0. Epub 2015 Nov 7. Neurochem Res. 2016. PMID: 26547196
-
Action of intravenously administered talipexole on the rat striatal neurons receiving excitatory input from nigral dopamine neurons.Psychopharmacology (Berl). 1995 Aug;120(4):369-75. doi: 10.1007/BF02245807. Psychopharmacology (Berl). 1995. PMID: 8539316
-
Role of dopamine receptors in the dual effect of naloxone on quinpirole-induced yawning in morphine pretreated rats.Naunyn Schmiedebergs Arch Pharmacol. 1993 May;347(5):478-82. doi: 10.1007/BF00166738. Naunyn Schmiedebergs Arch Pharmacol. 1993. PMID: 8100615
-
Distinct Effects of Chronic Dopaminergic Stimulation on Hippocampal Neurogenesis and Striatal Doublecortin Expression in Adult Mice.Front Neurosci. 2016 Mar 11;10:77. doi: 10.3389/fnins.2016.00077. eCollection 2016. Front Neurosci. 2016. PMID: 27013940 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources